nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—restless legs syndrome—Pregabalin—epilepsy syndrome	0.107	0.267	CpDpCtD
Ropinirole—restless legs syndrome—Carbamazepine—epilepsy syndrome	0.0957	0.238	CpDpCtD
Ropinirole—ADRA2A—epilepsy syndrome	0.091	0.471	CbGaD
Ropinirole—restless legs syndrome—Clonazepam—epilepsy syndrome	0.0765	0.19	CpDpCtD
Ropinirole—restless legs syndrome—Gabapentin—epilepsy syndrome	0.0616	0.153	CpDpCtD
Ropinirole—HTR2A—epilepsy syndrome	0.0534	0.276	CbGaD
Ropinirole—CYP2D6—epilepsy syndrome	0.0488	0.253	CbGaD
Ropinirole—Parkinson's disease—Clonazepam—epilepsy syndrome	0.0336	0.0835	CpDpCtD
Ropinirole—Parkinson's disease—Gabapentin—epilepsy syndrome	0.027	0.0673	CpDpCtD
Ropinirole—CYP1A2—Carbamazepine—epilepsy syndrome	0.00903	0.0662	CbGbCtD
Ropinirole—CYP1A2—Primidone—epilepsy syndrome	0.00843	0.0618	CbGbCtD
Ropinirole—CYP1A2—Propofol—epilepsy syndrome	0.00755	0.0554	CbGbCtD
Ropinirole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00753	0.0552	CbGbCtD
Ropinirole—CYP1A2—Phenobarbital—epilepsy syndrome	0.00722	0.0529	CbGbCtD
Ropinirole—CYP3A4—Felbamate—epilepsy syndrome	0.007	0.0513	CbGbCtD
Ropinirole—CYP3A4—Trimethadione—epilepsy syndrome	0.007	0.0513	CbGbCtD
Ropinirole—CYP1A2—Diazepam—epilepsy syndrome	0.00684	0.0502	CbGbCtD
Ropinirole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00658	0.0483	CbGbCtD
Ropinirole—CYP2D6—Propofol—epilepsy syndrome	0.00622	0.0456	CbGbCtD
Ropinirole—CYP3A4—Clonazepam—epilepsy syndrome	0.00595	0.0436	CbGbCtD
Ropinirole—CYP3A4—Clobazam—epilepsy syndrome	0.00571	0.0418	CbGbCtD
Ropinirole—CYP1A2—Valproic Acid—epilepsy syndrome	0.00539	0.0395	CbGbCtD
Ropinirole—CYP3A4—Rufinamide—epilepsy syndrome	0.00485	0.0356	CbGbCtD
Ropinirole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00473	0.0347	CbGbCtD
Ropinirole—CYP3A4—Primidone—epilepsy syndrome	0.00442	0.0324	CbGbCtD
Ropinirole—HTR1D—meninx—epilepsy syndrome	0.00438	0.103	CbGeAlD
Ropinirole—CYP3A4—Phenytoin—epilepsy syndrome	0.00424	0.0311	CbGbCtD
Ropinirole—CYP3A4—Propofol—epilepsy syndrome	0.00396	0.029	CbGbCtD
Ropinirole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00378	0.0277	CbGbCtD
Ropinirole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00378	0.0277	CbGbCtD
Ropinirole—CYP3A4—Midazolam—epilepsy syndrome	0.00373	0.0273	CbGbCtD
Ropinirole—CYP3A4—Diazepam—epilepsy syndrome	0.00359	0.0263	CbGbCtD
Ropinirole—CYP3A4—Zonisamide—epilepsy syndrome	0.0035	0.0256	CbGbCtD
Ropinirole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00283	0.0207	CbGbCtD
Ropinirole—CYP3A4—Topiramate—epilepsy syndrome	0.00255	0.0187	CbGbCtD
Ropinirole—HTR2A—phrenic nerve—epilepsy syndrome	0.00235	0.0555	CbGeAlD
Ropinirole—DRD3—telencephalic ventricle—epilepsy syndrome	0.00179	0.0421	CbGeAlD
Ropinirole—DRD1—telencephalic ventricle—epilepsy syndrome	0.00128	0.0302	CbGeAlD
Ropinirole—HTR2A—locus ceruleus—epilepsy syndrome	0.00105	0.0248	CbGeAlD
Ropinirole—DRD5—ganglion—epilepsy syndrome	0.00104	0.0246	CbGeAlD
Ropinirole—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00104	0.0244	CbGeAlD
Ropinirole—HTR1D—telencephalic ventricle—epilepsy syndrome	0.001	0.0237	CbGeAlD
Ropinirole—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000994	0.0234	CbGeAlD
Ropinirole—HTR2A—cerebellar cortex—epilepsy syndrome	0.000857	0.0202	CbGeAlD
Ropinirole—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000837	0.0197	CbGeAlD
Ropinirole—HTR2A—vagus nerve—epilepsy syndrome	0.000805	0.019	CbGeAlD
Ropinirole—DRD1—ganglion—epilepsy syndrome	0.000797	0.0188	CbGeAlD
Ropinirole—DRD2—telencephalic ventricle—epilepsy syndrome	0.000756	0.0178	CbGeAlD
Ropinirole—HTR1B—ganglion—epilepsy syndrome	0.000645	0.0152	CbGeAlD
Ropinirole—HTR1D—ganglion—epilepsy syndrome	0.000625	0.0147	CbGeAlD
Ropinirole—HTR2C—ganglion—epilepsy syndrome	0.000619	0.0146	CbGeAlD
Ropinirole—HTR2A—pons—epilepsy syndrome	0.000606	0.0143	CbGeAlD
Ropinirole—HTR2A—autonomic nervous system—epilepsy syndrome	0.000559	0.0132	CbGeAlD
Ropinirole—HTR1A—ganglion—epilepsy syndrome	0.000521	0.0123	CbGeAlD
Ropinirole—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000499	0.0118	CbGeAlD
Ropinirole—DRD2—ganglion—epilepsy syndrome	0.000471	0.0111	CbGeAlD
Ropinirole—DRD5—forebrain—epilepsy syndrome	0.000437	0.0103	CbGeAlD
Ropinirole—DRD5—telencephalon—epilepsy syndrome	0.000402	0.00948	CbGeAlD
Ropinirole—HTR1A—hindbrain—epilepsy syndrome	0.000395	0.00931	CbGeAlD
Ropinirole—DRD2—hindbrain—epilepsy syndrome	0.000357	0.00841	CbGeAlD
Ropinirole—DRD1—brainstem—epilepsy syndrome	0.000346	0.00816	CbGeAlD
Ropinirole—DRD1—forebrain—epilepsy syndrome	0.000334	0.00788	CbGeAlD
Ropinirole—HTR2A—ganglion—epilepsy syndrome	0.00031	0.00732	CbGeAlD
Ropinirole—DRD1—telencephalon—epilepsy syndrome	0.000307	0.00724	CbGeAlD
Ropinirole—HTR1B—brainstem—epilepsy syndrome	0.000281	0.00661	CbGeAlD
Ropinirole—DRD4—brain—epilepsy syndrome	0.000275	0.00649	CbGeAlD
Ropinirole—HTR1D—brainstem—epilepsy syndrome	0.000272	0.0064	CbGeAlD
Ropinirole—HTR1B—forebrain—epilepsy syndrome	0.000271	0.00638	CbGeAlD
Ropinirole—HTR2C—brainstem—epilepsy syndrome	0.000269	0.00634	CbGeAlD
Ropinirole—DRD3—head—epilepsy syndrome	0.000267	0.0063	CbGeAlD
Ropinirole—HTR1D—forebrain—epilepsy syndrome	0.000262	0.00618	CbGeAlD
Ropinirole—HTR2C—forebrain—epilepsy syndrome	0.00026	0.00612	CbGeAlD
Ropinirole—DRD3—nervous system—epilepsy syndrome	0.000253	0.00597	CbGeAlD
Ropinirole—DRD5—head—epilepsy syndrome	0.00025	0.0059	CbGeAlD
Ropinirole—HTR1B—telencephalon—epilepsy syndrome	0.000249	0.00587	CbGeAlD
Ropinirole—DRD3—central nervous system—epilepsy syndrome	0.000244	0.00575	CbGeAlD
Ropinirole—HTR2B—forebrain—epilepsy syndrome	0.000244	0.00575	CbGeAlD
Ropinirole—HTR1D—telencephalon—epilepsy syndrome	0.000241	0.00568	CbGeAlD
Ropinirole—HTR2C—telencephalon—epilepsy syndrome	0.000239	0.00563	CbGeAlD
Ropinirole—DRD5—nervous system—epilepsy syndrome	0.000237	0.0056	CbGeAlD
Ropinirole—HTR2A—hindbrain—epilepsy syndrome	0.000235	0.00555	CbGeAlD
Ropinirole—DRD5—central nervous system—epilepsy syndrome	0.000229	0.00539	CbGeAlD
Ropinirole—HTR1A—brainstem—epilepsy syndrome	0.000226	0.00534	CbGeAlD
Ropinirole—HTR2B—telencephalon—epilepsy syndrome	0.000224	0.00529	CbGeAlD
Ropinirole—DRD1—midbrain—epilepsy syndrome	0.000221	0.0052	CbGeAlD
Ropinirole—HTR1A—forebrain—epilepsy syndrome	0.000219	0.00515	CbGeAlD
Ropinirole—CYP2D6—hindbrain—epilepsy syndrome	0.000214	0.00505	CbGeAlD
Ropinirole—DRD2—brainstem—epilepsy syndrome	0.000205	0.00482	CbGeAlD
Ropinirole—HTR1A—telencephalon—epilepsy syndrome	0.000201	0.00474	CbGeAlD
Ropinirole—DRD2—forebrain—epilepsy syndrome	0.000197	0.00465	CbGeAlD
Ropinirole—DRD3—brain—epilepsy syndrome	0.000194	0.00456	CbGeAlD
Ropinirole—DRD1—head—epilepsy syndrome	0.000191	0.00451	CbGeAlD
Ropinirole—HTR2C—medulla oblongata—epilepsy syndrome	0.000188	0.00442	CbGeAlD
Ropinirole—DRD2—telencephalon—epilepsy syndrome	0.000182	0.00428	CbGeAlD
Ropinirole—DRD5—brain—epilepsy syndrome	0.000181	0.00428	CbGeAlD
Ropinirole—DRD1—nervous system—epilepsy syndrome	0.000181	0.00428	CbGeAlD
Ropinirole—HTR1B—midbrain—epilepsy syndrome	0.000179	0.00421	CbGeAlD
Ropinirole—ADRA2C—telencephalon—epilepsy syndrome	0.000176	0.00416	CbGeAlD
Ropinirole—DRD1—central nervous system—epilepsy syndrome	0.000175	0.00412	CbGeAlD
Ropinirole—HTR1B—spinal cord—epilepsy syndrome	0.000174	0.00411	CbGeAlD
Ropinirole—HTR1D—midbrain—epilepsy syndrome	0.000173	0.00408	CbGeAlD
Ropinirole—HTR2C—midbrain—epilepsy syndrome	0.000171	0.00404	CbGeAlD
Ropinirole—HTR2C—spinal cord—epilepsy syndrome	0.000167	0.00394	CbGeAlD
Ropinirole—HTR1B—head—epilepsy syndrome	0.000155	0.00365	CbGeAlD
Ropinirole—ADRA2A—forebrain—epilepsy syndrome	0.000153	0.00361	CbGeAlD
Ropinirole—HTR1D—head—epilepsy syndrome	0.00015	0.00354	CbGeAlD
Ropinirole—HTR2C—head—epilepsy syndrome	0.000149	0.0035	CbGeAlD
Ropinirole—HTR1B—nervous system—epilepsy syndrome	0.000147	0.00346	CbGeAlD
Ropinirole—HTR1A—midbrain—epilepsy syndrome	0.000144	0.0034	CbGeAlD
Ropinirole—HTR1D—nervous system—epilepsy syndrome	0.000142	0.00335	CbGeAlD
Ropinirole—HTR1B—central nervous system—epilepsy syndrome	0.000142	0.00334	CbGeAlD
Ropinirole—HTR2C—nervous system—epilepsy syndrome	0.000141	0.00332	CbGeAlD
Ropinirole—ADRA2A—telencephalon—epilepsy syndrome	0.000141	0.00332	CbGeAlD
Ropinirole—HTR1A—spinal cord—epilepsy syndrome	0.000141	0.00332	CbGeAlD
Ropinirole—HTR2B—head—epilepsy syndrome	0.00014	0.00329	CbGeAlD
Ropinirole—ADRA2C—medulla oblongata—epilepsy syndrome	0.000139	0.00327	CbGeAlD
Ropinirole—DRD1—brain—epilepsy syndrome	0.000139	0.00327	CbGeAlD
Ropinirole—HTR1D—central nervous system—epilepsy syndrome	0.000137	0.00323	CbGeAlD
Ropinirole—HTR2C—central nervous system—epilepsy syndrome	0.000136	0.0032	CbGeAlD
Ropinirole—HTR2A—brainstem—epilepsy syndrome	0.000135	0.00318	CbGeAlD
Ropinirole—HTR2B—nervous system—epilepsy syndrome	0.000132	0.00312	CbGeAlD
Ropinirole—DRD2—midbrain—epilepsy syndrome	0.00013	0.00307	CbGeAlD
Ropinirole—HTR2A—forebrain—epilepsy syndrome	0.00013	0.00307	CbGeAlD
Ropinirole—HTR2B—central nervous system—epilepsy syndrome	0.000127	0.003	CbGeAlD
Ropinirole—ADRA2C—midbrain—epilepsy syndrome	0.000127	0.00299	CbGeAlD
Ropinirole—HTR1A—head—epilepsy syndrome	0.000125	0.00295	CbGeAlD
Ropinirole—ADRA2C—spinal cord—epilepsy syndrome	0.000124	0.00291	CbGeAlD
Ropinirole—CYP2D6—brainstem—epilepsy syndrome	0.000123	0.0029	CbGeAlD
Ropinirole—HTR2A—telencephalon—epilepsy syndrome	0.00012	0.00282	CbGeAlD
Ropinirole—CYP2D6—forebrain—epilepsy syndrome	0.000119	0.0028	CbGeAlD
Ropinirole—HTR1A—nervous system—epilepsy syndrome	0.000119	0.0028	CbGeAlD
Ropinirole—HTR1A—central nervous system—epilepsy syndrome	0.000114	0.00269	CbGeAlD
Ropinirole—DRD2—head—epilepsy syndrome	0.000113	0.00266	CbGeAlD
Ropinirole—HTR1B—brain—epilepsy syndrome	0.000112	0.00265	CbGeAlD
Ropinirole—HTR1A—cerebellum—epilepsy syndrome	0.000112	0.00263	CbGeAlD
Ropinirole—ADRA2A—medulla oblongata—epilepsy syndrome	0.000111	0.00261	CbGeAlD
Ropinirole—ADRA2C—head—epilepsy syndrome	0.00011	0.00259	CbGeAlD
Ropinirole—CYP2D6—telencephalon—epilepsy syndrome	0.000109	0.00257	CbGeAlD
Ropinirole—HTR1D—brain—epilepsy syndrome	0.000109	0.00256	CbGeAlD
Ropinirole—HTR2C—brain—epilepsy syndrome	0.000108	0.00254	CbGeAlD
Ropinirole—DRD2—nervous system—epilepsy syndrome	0.000107	0.00253	CbGeAlD
Ropinirole—ADRA2C—nervous system—epilepsy syndrome	0.000104	0.00246	CbGeAlD
Ropinirole—DRD2—central nervous system—epilepsy syndrome	0.000103	0.00243	CbGeAlD
Ropinirole—HTR2B—brain—epilepsy syndrome	0.000101	0.00239	CbGeAlD
Ropinirole—ADRA2A—midbrain—epilepsy syndrome	0.000101	0.00238	CbGeAlD
Ropinirole—DRD2—cerebellum—epilepsy syndrome	0.000101	0.00238	CbGeAlD
Ropinirole—ADRA2C—central nervous system—epilepsy syndrome	0.0001	0.00236	CbGeAlD
Ropinirole—ADRA2A—spinal cord—epilepsy syndrome	9.87e-05	0.00233	CbGeAlD
Ropinirole—ADRA2C—cerebellum—epilepsy syndrome	9.8e-05	0.00231	CbGeAlD
Ropinirole—HTR2A—medulla oblongata—epilepsy syndrome	9.41e-05	0.00222	CbGeAlD
Ropinirole—HTR1A—brain—epilepsy syndrome	9.07e-05	0.00214	CbGeAlD
Ropinirole—ADRA2A—head—epilepsy syndrome	8.77e-05	0.00207	CbGeAlD
Ropinirole—HTR2A—midbrain—epilepsy syndrome	8.6e-05	0.00203	CbGeAlD
Ropinirole—HTR2A—spinal cord—epilepsy syndrome	8.39e-05	0.00198	CbGeAlD
Ropinirole—ADRA2A—nervous system—epilepsy syndrome	8.31e-05	0.00196	CbGeAlD
Ropinirole—DRD2—brain—epilepsy syndrome	8.19e-05	0.00193	CbGeAlD
Ropinirole—ADRA2A—central nervous system—epilepsy syndrome	8e-05	0.00189	CbGeAlD
Ropinirole—ADRA2C—brain—epilepsy syndrome	7.96e-05	0.00188	CbGeAlD
Ropinirole—ADRA2A—cerebellum—epilepsy syndrome	7.82e-05	0.00184	CbGeAlD
Ropinirole—HTR2A—head—epilepsy syndrome	7.46e-05	0.00176	CbGeAlD
Ropinirole—HTR2A—nervous system—epilepsy syndrome	7.07e-05	0.00167	CbGeAlD
Ropinirole—HTR2A—central nervous system—epilepsy syndrome	6.81e-05	0.0016	CbGeAlD
Ropinirole—CYP2D6—head—epilepsy syndrome	6.79e-05	0.0016	CbGeAlD
Ropinirole—HTR2A—cerebellum—epilepsy syndrome	6.65e-05	0.00157	CbGeAlD
Ropinirole—CYP3A4—nervous system—epilepsy syndrome	6.54e-05	0.00154	CbGeAlD
Ropinirole—CYP2D6—nervous system—epilepsy syndrome	6.44e-05	0.00152	CbGeAlD
Ropinirole—ADRA2A—brain—epilepsy syndrome	6.35e-05	0.0015	CbGeAlD
Ropinirole—CYP3A4—central nervous system—epilepsy syndrome	6.3e-05	0.00149	CbGeAlD
Ropinirole—CYP2D6—central nervous system—epilepsy syndrome	6.2e-05	0.00146	CbGeAlD
Ropinirole—CYP2D6—cerebellum—epilepsy syndrome	6.06e-05	0.00143	CbGeAlD
Ropinirole—HTR2A—brain—epilepsy syndrome	5.4e-05	0.00127	CbGeAlD
Ropinirole—CYP2D6—brain—epilepsy syndrome	4.92e-05	0.00116	CbGeAlD
Ropinirole—Diarrhoea—Clonazepam—epilepsy syndrome	1.04e-05	6.8e-05	CcSEcCtD
Ropinirole—Anaemia—Gabapentin—epilepsy syndrome	1.04e-05	6.79e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.04e-05	6.78e-05	CcSEcCtD
Ropinirole—Hypotension—Valproic Acid—epilepsy syndrome	1.03e-05	6.76e-05	CcSEcCtD
Ropinirole—Asthenia—Carbamazepine—epilepsy syndrome	1.03e-05	6.76e-05	CcSEcCtD
Ropinirole—Agitation—Gabapentin—epilepsy syndrome	1.03e-05	6.75e-05	CcSEcCtD
Ropinirole—Diarrhoea—Phenytoin—epilepsy syndrome	1.03e-05	6.75e-05	CcSEcCtD
Ropinirole—Discomfort—Pregabalin—epilepsy syndrome	1.03e-05	6.74e-05	CcSEcCtD
Ropinirole—Nausea—Fosphenytoin—epilepsy syndrome	1.03e-05	6.74e-05	CcSEcCtD
Ropinirole—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.03e-05	6.72e-05	CcSEcCtD
Ropinirole—Angioedema—Gabapentin—epilepsy syndrome	1.03e-05	6.71e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.02e-05	6.71e-05	CcSEcCtD
Ropinirole—Vomiting—Felbamate—epilepsy syndrome	1.02e-05	6.7e-05	CcSEcCtD
Ropinirole—Dry mouth—Pregabalin—epilepsy syndrome	1.02e-05	6.67e-05	CcSEcCtD
Ropinirole—Pruritus—Carbamazepine—epilepsy syndrome	1.02e-05	6.66e-05	CcSEcCtD
Ropinirole—Rash—Felbamate—epilepsy syndrome	1.01e-05	6.64e-05	CcSEcCtD
Ropinirole—Eye disorder—Topiramate—epilepsy syndrome	1.01e-05	6.64e-05	CcSEcCtD
Ropinirole—Dermatitis—Felbamate—epilepsy syndrome	1.01e-05	6.63e-05	CcSEcCtD
Ropinirole—Malaise—Gabapentin—epilepsy syndrome	1.01e-05	6.63e-05	CcSEcCtD
Ropinirole—Tinnitus—Topiramate—epilepsy syndrome	1.01e-05	6.62e-05	CcSEcCtD
Ropinirole—Vertigo—Gabapentin—epilepsy syndrome	1.01e-05	6.6e-05	CcSEcCtD
Ropinirole—Headache—Felbamate—epilepsy syndrome	1.01e-05	6.6e-05	CcSEcCtD
Ropinirole—Confusional state—Pregabalin—epilepsy syndrome	1.01e-05	6.59e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.01e-05	6.59e-05	CcSEcCtD
Ropinirole—Flushing—Topiramate—epilepsy syndrome	1.01e-05	6.59e-05	CcSEcCtD
Ropinirole—Cardiac disorder—Topiramate—epilepsy syndrome	1.01e-05	6.59e-05	CcSEcCtD
Ropinirole—Syncope—Gabapentin—epilepsy syndrome	1.01e-05	6.59e-05	CcSEcCtD
Ropinirole—Leukopenia—Gabapentin—epilepsy syndrome	1e-05	6.58e-05	CcSEcCtD
Ropinirole—Dizziness—Clonazepam—epilepsy syndrome	1e-05	6.57e-05	CcSEcCtD
Ropinirole—Nausea—Vigabatrin—epilepsy syndrome	1e-05	6.57e-05	CcSEcCtD
Ropinirole—Vomiting—Zonisamide—epilepsy syndrome	1e-05	6.55e-05	CcSEcCtD
Ropinirole—Insomnia—Valproic Acid—epilepsy syndrome	1e-05	6.54e-05	CcSEcCtD
Ropinirole—Oedema—Pregabalin—epilepsy syndrome	9.99e-06	6.54e-05	CcSEcCtD
Ropinirole—Asthenia—Lamotrigine—epilepsy syndrome	9.98e-06	6.53e-05	CcSEcCtD
Ropinirole—Dizziness—Phenytoin—epilepsy syndrome	9.97e-06	6.53e-05	CcSEcCtD
Ropinirole—Rash—Zonisamide—epilepsy syndrome	9.93e-06	6.5e-05	CcSEcCtD
Ropinirole—Infection—Pregabalin—epilepsy syndrome	9.93e-06	6.5e-05	CcSEcCtD
Ropinirole—Paraesthesia—Valproic Acid—epilepsy syndrome	9.92e-06	6.5e-05	CcSEcCtD
Ropinirole—Palpitations—Gabapentin—epilepsy syndrome	9.92e-06	6.49e-05	CcSEcCtD
Ropinirole—Dermatitis—Zonisamide—epilepsy syndrome	9.92e-06	6.49e-05	CcSEcCtD
Ropinirole—Dizziness—Oxcarbazepine—epilepsy syndrome	9.92e-06	6.49e-05	CcSEcCtD
Ropinirole—Nausea—Diazepam—epilepsy syndrome	9.87e-06	6.46e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Gabapentin—epilepsy syndrome	9.87e-06	6.46e-05	CcSEcCtD
Ropinirole—Headache—Zonisamide—epilepsy syndrome	9.87e-06	6.46e-05	CcSEcCtD
Ropinirole—Dyspnoea—Valproic Acid—epilepsy syndrome	9.85e-06	6.45e-05	CcSEcCtD
Ropinirole—Diarrhoea—Carbamazepine—epilepsy syndrome	9.85e-06	6.45e-05	CcSEcCtD
Ropinirole—Angiopathy—Topiramate—epilepsy syndrome	9.84e-06	6.44e-05	CcSEcCtD
Ropinirole—Pruritus—Lamotrigine—epilepsy syndrome	9.84e-06	6.44e-05	CcSEcCtD
Ropinirole—Shock—Pregabalin—epilepsy syndrome	9.83e-06	6.43e-05	CcSEcCtD
Ropinirole—Somnolence—Valproic Acid—epilepsy syndrome	9.83e-06	6.43e-05	CcSEcCtD
Ropinirole—Immune system disorder—Topiramate—epilepsy syndrome	9.8e-06	6.41e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Pregabalin—epilepsy syndrome	9.8e-06	6.41e-05	CcSEcCtD
Ropinirole—Cough—Gabapentin—epilepsy syndrome	9.8e-06	6.41e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.78e-06	6.4e-05	CcSEcCtD
Ropinirole—Mediastinal disorder—Topiramate—epilepsy syndrome	9.78e-06	6.4e-05	CcSEcCtD
Ropinirole—Tachycardia—Pregabalin—epilepsy syndrome	9.75e-06	6.38e-05	CcSEcCtD
Ropinirole—Chills—Topiramate—epilepsy syndrome	9.73e-06	6.37e-05	CcSEcCtD
Ropinirole—Dyspepsia—Valproic Acid—epilepsy syndrome	9.73e-06	6.37e-05	CcSEcCtD
Ropinirole—Convulsion—Gabapentin—epilepsy syndrome	9.73e-06	6.37e-05	CcSEcCtD
Ropinirole—Skin disorder—Pregabalin—epilepsy syndrome	9.71e-06	6.35e-05	CcSEcCtD
Ropinirole—Hypertension—Gabapentin—epilepsy syndrome	9.69e-06	6.34e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.66e-06	6.32e-05	CcSEcCtD
Ropinirole—Vomiting—Clonazepam—epilepsy syndrome	9.65e-06	6.32e-05	CcSEcCtD
Ropinirole—Decreased appetite—Valproic Acid—epilepsy syndrome	9.61e-06	6.29e-05	CcSEcCtD
Ropinirole—Alopecia—Topiramate—epilepsy syndrome	9.59e-06	6.28e-05	CcSEcCtD
Ropinirole—Vomiting—Phenytoin—epilepsy syndrome	9.59e-06	6.27e-05	CcSEcCtD
Ropinirole—Rash—Clonazepam—epilepsy syndrome	9.57e-06	6.26e-05	CcSEcCtD
Ropinirole—Dermatitis—Clonazepam—epilepsy syndrome	9.56e-06	6.26e-05	CcSEcCtD
Ropinirole—Myalgia—Gabapentin—epilepsy syndrome	9.56e-06	6.26e-05	CcSEcCtD
Ropinirole—Arthralgia—Gabapentin—epilepsy syndrome	9.56e-06	6.26e-05	CcSEcCtD
Ropinirole—Chest pain—Gabapentin—epilepsy syndrome	9.56e-06	6.26e-05	CcSEcCtD
Ropinirole—Nausea—Felbamate—epilepsy syndrome	9.56e-06	6.26e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.54e-06	6.25e-05	CcSEcCtD
Ropinirole—Vomiting—Oxcarbazepine—epilepsy syndrome	9.54e-06	6.24e-05	CcSEcCtD
Ropinirole—Fatigue—Valproic Acid—epilepsy syndrome	9.53e-06	6.24e-05	CcSEcCtD
Ropinirole—Anxiety—Gabapentin—epilepsy syndrome	9.52e-06	6.23e-05	CcSEcCtD
Ropinirole—Anorexia—Pregabalin—epilepsy syndrome	9.52e-06	6.23e-05	CcSEcCtD
Ropinirole—Dizziness—Carbamazepine—epilepsy syndrome	9.52e-06	6.23e-05	CcSEcCtD
Ropinirole—Diarrhoea—Lamotrigine—epilepsy syndrome	9.52e-06	6.23e-05	CcSEcCtD
Ropinirole—Headache—Clonazepam—epilepsy syndrome	9.51e-06	6.22e-05	CcSEcCtD
Ropinirole—Rash—Phenytoin—epilepsy syndrome	9.51e-06	6.22e-05	CcSEcCtD
Ropinirole—Mental disorder—Topiramate—epilepsy syndrome	9.51e-06	6.22e-05	CcSEcCtD
Ropinirole—Dermatitis—Phenytoin—epilepsy syndrome	9.5e-06	6.22e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.49e-06	6.21e-05	CcSEcCtD
Ropinirole—Rash—Oxcarbazepine—epilepsy syndrome	9.46e-06	6.19e-05	CcSEcCtD
Ropinirole—Pain—Valproic Acid—epilepsy syndrome	9.45e-06	6.19e-05	CcSEcCtD
Ropinirole—Constipation—Valproic Acid—epilepsy syndrome	9.45e-06	6.19e-05	CcSEcCtD
Ropinirole—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.45e-06	6.18e-05	CcSEcCtD
Ropinirole—Headache—Phenytoin—epilepsy syndrome	9.44e-06	6.18e-05	CcSEcCtD
Ropinirole—Malnutrition—Topiramate—epilepsy syndrome	9.44e-06	6.18e-05	CcSEcCtD
Ropinirole—Discomfort—Gabapentin—epilepsy syndrome	9.44e-06	6.18e-05	CcSEcCtD
Ropinirole—Headache—Oxcarbazepine—epilepsy syndrome	9.39e-06	6.15e-05	CcSEcCtD
Ropinirole—Nausea—Zonisamide—epilepsy syndrome	9.35e-06	6.12e-05	CcSEcCtD
Ropinirole—Dry mouth—Gabapentin—epilepsy syndrome	9.35e-06	6.12e-05	CcSEcCtD
Ropinirole—Hypotension—Pregabalin—epilepsy syndrome	9.34e-06	6.11e-05	CcSEcCtD
Ropinirole—Flatulence—Topiramate—epilepsy syndrome	9.31e-06	6.09e-05	CcSEcCtD
Ropinirole—Tension—Topiramate—epilepsy syndrome	9.27e-06	6.07e-05	CcSEcCtD
Ropinirole—Dysgeusia—Topiramate—epilepsy syndrome	9.25e-06	6.05e-05	CcSEcCtD
Ropinirole—Confusional state—Gabapentin—epilepsy syndrome	9.24e-06	6.05e-05	CcSEcCtD
Ropinirole—Dizziness—Lamotrigine—epilepsy syndrome	9.2e-06	6.02e-05	CcSEcCtD
Ropinirole—Nervousness—Topiramate—epilepsy syndrome	9.17e-06	6e-05	CcSEcCtD
Ropinirole—Oedema—Gabapentin—epilepsy syndrome	9.16e-06	6e-05	CcSEcCtD
Ropinirole—Vomiting—Carbamazepine—epilepsy syndrome	9.15e-06	5.99e-05	CcSEcCtD
Ropinirole—Back pain—Topiramate—epilepsy syndrome	9.14e-06	5.98e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.11e-06	5.96e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.1e-06	5.96e-05	CcSEcCtD
Ropinirole—Infection—Gabapentin—epilepsy syndrome	9.1e-06	5.96e-05	CcSEcCtD
Ropinirole—Muscle spasms—Topiramate—epilepsy syndrome	9.08e-06	5.94e-05	CcSEcCtD
Ropinirole—Rash—Carbamazepine—epilepsy syndrome	9.07e-06	5.94e-05	CcSEcCtD
Ropinirole—Dermatitis—Carbamazepine—epilepsy syndrome	9.07e-06	5.93e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.04e-06	5.92e-05	CcSEcCtD
Ropinirole—Insomnia—Pregabalin—epilepsy syndrome	9.04e-06	5.92e-05	CcSEcCtD
Ropinirole—Nausea—Clonazepam—epilepsy syndrome	9.02e-06	5.9e-05	CcSEcCtD
Ropinirole—Headache—Carbamazepine—epilepsy syndrome	9.02e-06	5.9e-05	CcSEcCtD
Ropinirole—Shock—Gabapentin—epilepsy syndrome	9.01e-06	5.9e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Gabapentin—epilepsy syndrome	8.99e-06	5.88e-05	CcSEcCtD
Ropinirole—Paraesthesia—Pregabalin—epilepsy syndrome	8.97e-06	5.87e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.97e-06	5.87e-05	CcSEcCtD
Ropinirole—Nausea—Phenytoin—epilepsy syndrome	8.96e-06	5.86e-05	CcSEcCtD
Ropinirole—Tachycardia—Gabapentin—epilepsy syndrome	8.94e-06	5.85e-05	CcSEcCtD
Ropinirole—Dyspnoea—Pregabalin—epilepsy syndrome	8.91e-06	5.83e-05	CcSEcCtD
Ropinirole—Nausea—Oxcarbazepine—epilepsy syndrome	8.91e-06	5.83e-05	CcSEcCtD
Ropinirole—Vision blurred—Topiramate—epilepsy syndrome	8.9e-06	5.83e-05	CcSEcCtD
Ropinirole—Skin disorder—Gabapentin—epilepsy syndrome	8.9e-06	5.83e-05	CcSEcCtD
Ropinirole—Somnolence—Pregabalin—epilepsy syndrome	8.88e-06	5.81e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.86e-06	5.8e-05	CcSEcCtD
Ropinirole—Tremor—Topiramate—epilepsy syndrome	8.85e-06	5.79e-05	CcSEcCtD
Ropinirole—Vomiting—Lamotrigine—epilepsy syndrome	8.84e-06	5.79e-05	CcSEcCtD
Ropinirole—Urticaria—Valproic Acid—epilepsy syndrome	8.78e-06	5.75e-05	CcSEcCtD
Ropinirole—Rash—Lamotrigine—epilepsy syndrome	8.77e-06	5.74e-05	CcSEcCtD
Ropinirole—Ill-defined disorder—Topiramate—epilepsy syndrome	8.76e-06	5.74e-05	CcSEcCtD
Ropinirole—Dermatitis—Lamotrigine—epilepsy syndrome	8.76e-06	5.74e-05	CcSEcCtD
Ropinirole—Abdominal pain—Valproic Acid—epilepsy syndrome	8.74e-06	5.72e-05	CcSEcCtD
Ropinirole—Body temperature increased—Valproic Acid—epilepsy syndrome	8.74e-06	5.72e-05	CcSEcCtD
Ropinirole—Anorexia—Gabapentin—epilepsy syndrome	8.73e-06	5.72e-05	CcSEcCtD
Ropinirole—Anaemia—Topiramate—epilepsy syndrome	8.73e-06	5.71e-05	CcSEcCtD
Ropinirole—Headache—Lamotrigine—epilepsy syndrome	8.71e-06	5.7e-05	CcSEcCtD
Ropinirole—Decreased appetite—Pregabalin—epilepsy syndrome	8.69e-06	5.69e-05	CcSEcCtD
Ropinirole—Agitation—Topiramate—epilepsy syndrome	8.68e-06	5.68e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.63e-06	5.65e-05	CcSEcCtD
Ropinirole—Fatigue—Pregabalin—epilepsy syndrome	8.61e-06	5.64e-05	CcSEcCtD
Ropinirole—Hypotension—Gabapentin—epilepsy syndrome	8.56e-06	5.6e-05	CcSEcCtD
Ropinirole—Nausea—Carbamazepine—epilepsy syndrome	8.55e-06	5.6e-05	CcSEcCtD
Ropinirole—Constipation—Pregabalin—epilepsy syndrome	8.54e-06	5.59e-05	CcSEcCtD
Ropinirole—Pain—Pregabalin—epilepsy syndrome	8.54e-06	5.59e-05	CcSEcCtD
Ropinirole—Malaise—Topiramate—epilepsy syndrome	8.52e-06	5.58e-05	CcSEcCtD
Ropinirole—Vertigo—Topiramate—epilepsy syndrome	8.49e-06	5.55e-05	CcSEcCtD
Ropinirole—Syncope—Topiramate—epilepsy syndrome	8.47e-06	5.54e-05	CcSEcCtD
Ropinirole—Leukopenia—Topiramate—epilepsy syndrome	8.45e-06	5.53e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.35e-06	5.46e-05	CcSEcCtD
Ropinirole—Palpitations—Topiramate—epilepsy syndrome	8.35e-06	5.46e-05	CcSEcCtD
Ropinirole—Loss of consciousness—Topiramate—epilepsy syndrome	8.3e-06	5.43e-05	CcSEcCtD
Ropinirole—Insomnia—Gabapentin—epilepsy syndrome	8.29e-06	5.42e-05	CcSEcCtD
Ropinirole—Nausea—Lamotrigine—epilepsy syndrome	8.26e-06	5.41e-05	CcSEcCtD
Ropinirole—Cough—Topiramate—epilepsy syndrome	8.24e-06	5.39e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Pregabalin—epilepsy syndrome	8.23e-06	5.39e-05	CcSEcCtD
Ropinirole—Paraesthesia—Gabapentin—epilepsy syndrome	8.23e-06	5.39e-05	CcSEcCtD
Ropinirole—Convulsion—Topiramate—epilepsy syndrome	8.18e-06	5.36e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.17e-06	5.35e-05	CcSEcCtD
Ropinirole—Dyspnoea—Gabapentin—epilepsy syndrome	8.17e-06	5.35e-05	CcSEcCtD
Ropinirole—Hypertension—Topiramate—epilepsy syndrome	8.15e-06	5.34e-05	CcSEcCtD
Ropinirole—Somnolence—Gabapentin—epilepsy syndrome	8.15e-06	5.33e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.14e-06	5.33e-05	CcSEcCtD
Ropinirole—Dyspepsia—Gabapentin—epilepsy syndrome	8.06e-06	5.28e-05	CcSEcCtD
Ropinirole—Myalgia—Topiramate—epilepsy syndrome	8.04e-06	5.26e-05	CcSEcCtD
Ropinirole—Arthralgia—Topiramate—epilepsy syndrome	8.04e-06	5.26e-05	CcSEcCtD
Ropinirole—Chest pain—Topiramate—epilepsy syndrome	8.04e-06	5.26e-05	CcSEcCtD
Ropinirole—Anxiety—Topiramate—epilepsy syndrome	8.01e-06	5.25e-05	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.99e-06	5.23e-05	CcSEcCtD
Ropinirole—Decreased appetite—Gabapentin—epilepsy syndrome	7.96e-06	5.21e-05	CcSEcCtD
Ropinirole—Discomfort—Topiramate—epilepsy syndrome	7.94e-06	5.2e-05	CcSEcCtD
Ropinirole—Urticaria—Pregabalin—epilepsy syndrome	7.94e-06	5.2e-05	CcSEcCtD
Ropinirole—Asthenia—Valproic Acid—epilepsy syndrome	7.93e-06	5.19e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.91e-06	5.18e-05	CcSEcCtD
Ropinirole—Fatigue—Gabapentin—epilepsy syndrome	7.9e-06	5.17e-05	CcSEcCtD
Ropinirole—Abdominal pain—Pregabalin—epilepsy syndrome	7.9e-06	5.17e-05	CcSEcCtD
Ropinirole—Body temperature increased—Pregabalin—epilepsy syndrome	7.9e-06	5.17e-05	CcSEcCtD
Ropinirole—Dry mouth—Topiramate—epilepsy syndrome	7.86e-06	5.15e-05	CcSEcCtD
Ropinirole—Constipation—Gabapentin—epilepsy syndrome	7.83e-06	5.13e-05	CcSEcCtD
Ropinirole—Pain—Gabapentin—epilepsy syndrome	7.83e-06	5.13e-05	CcSEcCtD
Ropinirole—Pruritus—Valproic Acid—epilepsy syndrome	7.82e-06	5.12e-05	CcSEcCtD
Ropinirole—Confusional state—Topiramate—epilepsy syndrome	7.77e-06	5.09e-05	CcSEcCtD
Ropinirole—Oedema—Topiramate—epilepsy syndrome	7.71e-06	5.05e-05	CcSEcCtD
Ropinirole—Infection—Topiramate—epilepsy syndrome	7.66e-06	5.01e-05	CcSEcCtD
Ropinirole—Shock—Topiramate—epilepsy syndrome	7.58e-06	4.96e-05	CcSEcCtD
Ropinirole—Diarrhoea—Valproic Acid—epilepsy syndrome	7.56e-06	4.95e-05	CcSEcCtD
Ropinirole—Nervous system disorder—Topiramate—epilepsy syndrome	7.56e-06	4.95e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Gabapentin—epilepsy syndrome	7.55e-06	4.94e-05	CcSEcCtD
Ropinirole—Thrombocytopenia—Topiramate—epilepsy syndrome	7.55e-06	4.94e-05	CcSEcCtD
Ropinirole—Tachycardia—Topiramate—epilepsy syndrome	7.52e-06	4.92e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.49e-06	4.9e-05	CcSEcCtD
Ropinirole—Skin disorder—Topiramate—epilepsy syndrome	7.49e-06	4.9e-05	CcSEcCtD
Ropinirole—Hyperhidrosis—Topiramate—epilepsy syndrome	7.45e-06	4.88e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Pregabalin—epilepsy syndrome	7.36e-06	4.82e-05	CcSEcCtD
Ropinirole—Anorexia—Topiramate—epilepsy syndrome	7.35e-06	4.81e-05	CcSEcCtD
Ropinirole—Dizziness—Valproic Acid—epilepsy syndrome	7.31e-06	4.78e-05	CcSEcCtD
Ropinirole—Urticaria—Gabapentin—epilepsy syndrome	7.28e-06	4.76e-05	CcSEcCtD
Ropinirole—Abdominal pain—Gabapentin—epilepsy syndrome	7.24e-06	4.74e-05	CcSEcCtD
Ropinirole—Body temperature increased—Gabapentin—epilepsy syndrome	7.24e-06	4.74e-05	CcSEcCtD
Ropinirole—Hypotension—Topiramate—epilepsy syndrome	7.2e-06	4.71e-05	CcSEcCtD
Ropinirole—Asthenia—Pregabalin—epilepsy syndrome	7.17e-06	4.69e-05	CcSEcCtD
Ropinirole—Pruritus—Pregabalin—epilepsy syndrome	7.07e-06	4.63e-05	CcSEcCtD
Ropinirole—Vomiting—Valproic Acid—epilepsy syndrome	7.03e-06	4.6e-05	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.02e-06	4.6e-05	CcSEcCtD
Ropinirole—Insomnia—Topiramate—epilepsy syndrome	6.97e-06	4.56e-05	CcSEcCtD
Ropinirole—Rash—Valproic Acid—epilepsy syndrome	6.97e-06	4.56e-05	CcSEcCtD
Ropinirole—Dermatitis—Valproic Acid—epilepsy syndrome	6.96e-06	4.56e-05	CcSEcCtD
Ropinirole—Headache—Valproic Acid—epilepsy syndrome	6.92e-06	4.53e-05	CcSEcCtD
Ropinirole—Paraesthesia—Topiramate—epilepsy syndrome	6.92e-06	4.53e-05	CcSEcCtD
Ropinirole—Dyspnoea—Topiramate—epilepsy syndrome	6.87e-06	4.5e-05	CcSEcCtD
Ropinirole—Somnolence—Topiramate—epilepsy syndrome	6.85e-06	4.49e-05	CcSEcCtD
Ropinirole—Diarrhoea—Pregabalin—epilepsy syndrome	6.84e-06	4.47e-05	CcSEcCtD
Ropinirole—Dyspepsia—Topiramate—epilepsy syndrome	6.79e-06	4.44e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Gabapentin—epilepsy syndrome	6.75e-06	4.42e-05	CcSEcCtD
Ropinirole—Decreased appetite—Topiramate—epilepsy syndrome	6.7e-06	4.39e-05	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.65e-06	4.36e-05	CcSEcCtD
Ropinirole—Fatigue—Topiramate—epilepsy syndrome	6.65e-06	4.35e-05	CcSEcCtD
Ropinirole—Dizziness—Pregabalin—epilepsy syndrome	6.61e-06	4.32e-05	CcSEcCtD
Ropinirole—Constipation—Topiramate—epilepsy syndrome	6.59e-06	4.31e-05	CcSEcCtD
Ropinirole—Pain—Topiramate—epilepsy syndrome	6.59e-06	4.31e-05	CcSEcCtD
Ropinirole—Asthenia—Gabapentin—epilepsy syndrome	6.57e-06	4.3e-05	CcSEcCtD
Ropinirole—Nausea—Valproic Acid—epilepsy syndrome	6.56e-06	4.3e-05	CcSEcCtD
Ropinirole—Pruritus—Gabapentin—epilepsy syndrome	6.48e-06	4.24e-05	CcSEcCtD
Ropinirole—Vomiting—Pregabalin—epilepsy syndrome	6.35e-06	4.16e-05	CcSEcCtD
Ropinirole—Feeling abnormal—Topiramate—epilepsy syndrome	6.35e-06	4.16e-05	CcSEcCtD
Ropinirole—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.3e-06	4.13e-05	CcSEcCtD
Ropinirole—Rash—Pregabalin—epilepsy syndrome	6.3e-06	4.12e-05	CcSEcCtD
Ropinirole—Dermatitis—Pregabalin—epilepsy syndrome	6.29e-06	4.12e-05	CcSEcCtD
Ropinirole—Diarrhoea—Gabapentin—epilepsy syndrome	6.27e-06	4.1e-05	CcSEcCtD
Ropinirole—Headache—Pregabalin—epilepsy syndrome	6.26e-06	4.1e-05	CcSEcCtD
Ropinirole—Urticaria—Topiramate—epilepsy syndrome	6.12e-06	4.01e-05	CcSEcCtD
Ropinirole—Abdominal pain—Topiramate—epilepsy syndrome	6.09e-06	3.99e-05	CcSEcCtD
Ropinirole—Body temperature increased—Topiramate—epilepsy syndrome	6.09e-06	3.99e-05	CcSEcCtD
Ropinirole—Dizziness—Gabapentin—epilepsy syndrome	6.06e-06	3.97e-05	CcSEcCtD
Ropinirole—Nausea—Pregabalin—epilepsy syndrome	5.93e-06	3.88e-05	CcSEcCtD
Ropinirole—Vomiting—Gabapentin—epilepsy syndrome	5.83e-06	3.81e-05	CcSEcCtD
Ropinirole—Rash—Gabapentin—epilepsy syndrome	5.78e-06	3.78e-05	CcSEcCtD
Ropinirole—Dermatitis—Gabapentin—epilepsy syndrome	5.77e-06	3.78e-05	CcSEcCtD
Ropinirole—Headache—Gabapentin—epilepsy syndrome	5.74e-06	3.76e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Topiramate—epilepsy syndrome	5.68e-06	3.72e-05	CcSEcCtD
Ropinirole—Asthenia—Topiramate—epilepsy syndrome	5.53e-06	3.62e-05	CcSEcCtD
Ropinirole—Pruritus—Topiramate—epilepsy syndrome	5.45e-06	3.57e-05	CcSEcCtD
Ropinirole—Nausea—Gabapentin—epilepsy syndrome	5.44e-06	3.56e-05	CcSEcCtD
Ropinirole—Diarrhoea—Topiramate—epilepsy syndrome	5.27e-06	3.45e-05	CcSEcCtD
Ropinirole—Dizziness—Topiramate—epilepsy syndrome	5.1e-06	3.34e-05	CcSEcCtD
Ropinirole—Vomiting—Topiramate—epilepsy syndrome	4.9e-06	3.21e-05	CcSEcCtD
Ropinirole—Rash—Topiramate—epilepsy syndrome	4.86e-06	3.18e-05	CcSEcCtD
Ropinirole—Dermatitis—Topiramate—epilepsy syndrome	4.86e-06	3.18e-05	CcSEcCtD
Ropinirole—Headache—Topiramate—epilepsy syndrome	4.83e-06	3.16e-05	CcSEcCtD
Ropinirole—Nausea—Topiramate—epilepsy syndrome	4.58e-06	3e-05	CcSEcCtD
Ropinirole—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.25e-06	1.7e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.25e-06	1.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.25e-06	1.7e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—TH—epilepsy syndrome	1.25e-06	1.69e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.24e-06	1.68e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	1.23e-06	1.68e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—RELA—epilepsy syndrome	1.23e-06	1.67e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—VEGFA—epilepsy syndrome	1.23e-06	1.67e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.23e-06	1.67e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.23e-06	1.67e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.66e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.22e-06	1.66e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.22e-06	1.66e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	1.22e-06	1.66e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.22e-06	1.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.22e-06	1.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.21e-06	1.65e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.21e-06	1.64e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MTOR—epilepsy syndrome	1.21e-06	1.64e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	1.2e-06	1.64e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.19e-06	1.61e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.19e-06	1.61e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—RELA—epilepsy syndrome	1.18e-06	1.61e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.18e-06	1.61e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.18e-06	1.61e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	1.18e-06	1.61e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ALB—epilepsy syndrome	1.18e-06	1.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.17e-06	1.59e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.17e-06	1.59e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.17e-06	1.58e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MTOR—epilepsy syndrome	1.16e-06	1.58e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	1.16e-06	1.57e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.16e-06	1.57e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	1.15e-06	1.56e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.15e-06	1.56e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.15e-06	1.56e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.14e-06	1.55e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	1.13e-06	1.54e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	1.13e-06	1.54e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	1.13e-06	1.54e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.13e-06	1.53e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.12e-06	1.53e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.12e-06	1.53e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.12e-06	1.53e-05	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.12e-06	1.52e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1.12e-06	1.52e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.12e-06	1.52e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.11e-06	1.51e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	1.11e-06	1.51e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.11e-06	1.51e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.1e-06	1.5e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.1e-06	1.5e-05	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.1e-06	1.49e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.09e-06	1.49e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.09e-06	1.48e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	1.09e-06	1.48e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	1.08e-06	1.47e-05	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	1.08e-06	1.47e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.08e-06	1.46e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.08e-06	1.46e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.07e-06	1.46e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.07e-06	1.46e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	1.07e-06	1.45e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—RELA—epilepsy syndrome	1.07e-06	1.45e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.06e-06	1.44e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.06e-06	1.44e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.06e-06	1.44e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.06e-06	1.44e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.05e-06	1.43e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TH—epilepsy syndrome	1.05e-06	1.43e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—RELA—epilepsy syndrome	1.05e-06	1.43e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.05e-06	1.43e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.05e-06	1.43e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.05e-06	1.42e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.04e-06	1.42e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.04e-06	1.42e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.04e-06	1.42e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.04e-06	1.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.04e-06	1.41e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.04e-06	1.41e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—JUN—epilepsy syndrome	1.04e-06	1.41e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	1.03e-06	1.4e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	1.4e-05	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.03e-06	1.4e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-06	1.4e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.03e-06	1.39e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.02e-06	1.39e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.02e-06	1.39e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1.02e-06	1.39e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.02e-06	1.38e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.02e-06	1.38e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.01e-06	1.38e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	1.01e-06	1.37e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1e-06	1.36e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	9.97e-07	1.36e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	9.95e-07	1.35e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	9.91e-07	1.35e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	9.88e-07	1.34e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	9.83e-07	1.34e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—POMC—epilepsy syndrome	9.81e-07	1.33e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	9.79e-07	1.33e-05	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	9.71e-07	1.32e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	9.66e-07	1.31e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	9.65e-07	1.31e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	9.64e-07	1.31e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	9.64e-07	1.31e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	9.62e-07	1.31e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	9.6e-07	1.31e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	9.6e-07	1.31e-05	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	9.58e-07	1.3e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—epilepsy syndrome	9.58e-07	1.3e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	9.56e-07	1.3e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	9.5e-07	1.29e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	9.49e-07	1.29e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	9.46e-07	1.29e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	9.44e-07	1.28e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	9.41e-07	1.28e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	9.35e-07	1.27e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—JUN—epilepsy syndrome	9.34e-07	1.27e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	9.32e-07	1.27e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SRC—epilepsy syndrome	9.31e-07	1.27e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GPX1—epilepsy syndrome	9.27e-07	1.26e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—JUN—epilepsy syndrome	9.22e-07	1.25e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	9.22e-07	1.25e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	9.17e-07	1.25e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.13e-07	1.24e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	9.12e-07	1.24e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	9.09e-07	1.24e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	9.07e-07	1.23e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	8.99e-07	1.22e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	8.97e-07	1.22e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	8.95e-07	1.22e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	8.89e-07	1.21e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	8.88e-07	1.21e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	8.82e-07	1.2e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	8.8e-07	1.2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	8.78e-07	1.19e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	8.7e-07	1.18e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	8.7e-07	1.18e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.69e-07	1.18e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CAT—epilepsy syndrome	8.69e-07	1.18e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	8.67e-07	1.18e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.66e-07	1.18e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	8.66e-07	1.18e-05	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	8.65e-07	1.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	8.59e-07	1.17e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	8.57e-07	1.17e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	8.54e-07	1.16e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	8.45e-07	1.15e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SRC—epilepsy syndrome	8.38e-07	1.14e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	8.38e-07	1.14e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.35e-07	1.14e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	8.32e-07	1.13e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	8.31e-07	1.13e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	8.27e-07	1.12e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SRC—epilepsy syndrome	8.27e-07	1.12e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.26e-07	1.12e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	8.23e-07	1.12e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.17e-07	1.11e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	8.16e-07	1.11e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TH—epilepsy syndrome	8.14e-07	1.11e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AGT—epilepsy syndrome	8.13e-07	1.11e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	8.1e-07	1.1e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	8.08e-07	1.1e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	8.05e-07	1.1e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RELA—epilepsy syndrome	8.05e-07	1.1e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	8.04e-07	1.09e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	8e-07	1.09e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	7.99e-07	1.09e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.97e-07	1.08e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	7.92e-07	1.08e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	7.9e-07	1.07e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.86e-07	1.07e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	7.85e-07	1.07e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	7.84e-07	1.07e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	7.82e-07	1.06e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	7.78e-07	1.06e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	7.78e-07	1.06e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	7.77e-07	1.06e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	7.77e-07	1.06e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	7.58e-07	1.03e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	7.56e-07	1.03e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	7.54e-07	1.03e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	7.47e-07	1.02e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	7.34e-07	9.98e-06	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	7.33e-07	9.97e-06	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	7.27e-07	9.89e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	7.26e-07	9.88e-06	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.21e-07	9.81e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	7.21e-07	9.8e-06	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	7.21e-07	9.8e-06	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	7.17e-07	9.75e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	7.15e-07	9.72e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	7.07e-07	9.61e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—JUN—epilepsy syndrome	7.06e-07	9.59e-06	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.02e-07	9.55e-06	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	6.98e-07	9.5e-06	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	6.97e-07	9.48e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	6.94e-07	9.44e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.89e-07	9.37e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	6.86e-07	9.33e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.84e-07	9.31e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.79e-07	9.24e-06	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	6.79e-07	9.24e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	6.75e-07	9.18e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.75e-07	9.18e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.7e-07	9.12e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	6.66e-07	9.05e-06	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.56e-07	8.92e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	6.55e-07	8.91e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.52e-07	8.87e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	6.5e-07	8.84e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SRC—epilepsy syndrome	6.33e-07	8.61e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	6.32e-07	8.59e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.24e-07	8.48e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	6.23e-07	8.47e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	6.16e-07	8.38e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	6.14e-07	8.36e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	6.06e-07	8.25e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.06e-07	8.24e-06	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	6e-07	8.17e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.96e-07	8.1e-06	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	5.88e-07	8e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.8e-07	7.88e-06	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	5.79e-07	7.87e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	5.66e-07	7.7e-06	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	5.52e-07	7.51e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.52e-07	7.5e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.46e-07	7.42e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.32e-07	7.23e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.29e-07	7.19e-06	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	5.21e-07	7.08e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.21e-07	7.08e-06	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—epilepsy syndrome	5.18e-07	7.05e-06	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	5.14e-07	6.99e-06	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	4.64e-07	6.31e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.62e-07	6.29e-06	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	4.48e-07	6.09e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.47e-07	6.08e-06	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	4.46e-07	6.06e-06	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	4.33e-07	5.89e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—epilepsy syndrome	4.21e-07	5.73e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.08e-07	5.55e-06	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.93e-07	5.35e-06	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.87e-07	5.26e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.57e-07	4.85e-06	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	3.52e-07	4.79e-06	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.74e-07	3.73e-06	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.32e-07	3.16e-06	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.79e-07	2.44e-06	CbGpPWpGaD
